Published in J Neurol Neurosurg Psychiatry on November 01, 2004
Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med (2009) 6.66
The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet (2007) 6.20
In utero antiepileptic drug exposure: fetal death and malformations. Neurology (2006) 3.64
IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study. Neurology (2014) 3.34
Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol (2013) 2.61
Effects of breastfeeding in children of women taking antiepileptic drugs. Neurology (2010) 2.38
Mortality and Morbidity During Delivery Hospitalization Among Pregnant Women With Epilepsy in the United States. JAMA Neurol (2015) 2.07
Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes. J Neurol (2010) 1.70
Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years. JAMA Pediatr (2014) 1.61
Foetal antiepileptic drug exposure and verbal versus non-verbal abilities at three years of age. Brain (2011) 1.52
The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry (2013) 1.45
Pregnancy with epilepsy: obstetric and neonatal outcome of a controlled study. Seizure (2009) 1.28
Cognitive/behavioral teratogenetic effects of antiepileptic drugs. Epilepsy Behav (2007) 1.22
Perinatal depression: treatment options and dilemmas. J Psychiatry Neurosci (2008) 1.22
Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes. Arch Dis Child Fetal Neonatal Ed (2005) 1.17
Teratogenicity of antiepileptic medications. Semin Neurol (2008) 1.16
Effects of fetal antiepileptic drug exposure: outcomes at age 4.5 years. Neurology (2012) 1.15
Curing epilepsy: progress and future directions. Epilepsy Behav (2009) 1.12
Antiepileptic drugs during pregnancy in primary care: a UK population based study. PLoS One (2012) 1.11
Child development following in utero exposure: levetiracetam vs sodium valproate. Neurology (2011) 1.06
Antiepileptic drugs during pregnancy: what is known and which AEDs seem to be safest? Epilepsia (2008) 1.04
Antiepileptic drug use in women of childbearing age. Epilepsy Behav (2009) 0.99
Exposure to antiepileptic drugs in utero and child development: a prospective population-based study. Epilepsia (2013) 0.98
Epilepsy in pregnancy. BMJ (2007) 0.97
Using current evidence in selecting antiepileptic drugs for use during pregnancy. Epilepsy Curr (2005) 0.95
Fetal antiepileptic drug exposure: motor, adaptive, and emotional/behavioral functioning at age 3 years. Epilepsy Behav (2011) 0.93
Preconception care: screening and management of chronic disease and promoting psychological health. Reprod Health (2014) 0.92
Antiepileptic drugs and pregnancy outcomes. Am J Med Genet A (2012) 0.92
Ensuring the safe and effective use of medications during pregnancy: planning and prevention through preconception care. Matern Child Health J (2006) 0.91
Impact of early life exposure to antiepileptic drugs on neurobehavioral outcomes based on laboratory animal and clinical research. Epilepsy Behav (2013) 0.90
A prospective study of cognitive fluency and originality in children exposed in utero to carbamazepine, lamotrigine, or valproate monotherapy. Epilepsy Behav (2009) 0.90
Neuropsychological effects of antiepileptic drugs (carbamazepine versus valproate) in adult males with epilepsy. Neuropsychiatr Dis Treat (2009) 0.88
Antiepileptic drugs in women with epilepsy during pregnancy. Ther Adv Drug Saf (2012) 0.87
Neonatal episodic hypoglycemia: a finding of valproic acid withdrawal. J Clin Res Pediatr Endocrinol (2010) 0.87
Cognitive abilities and behaviour of children exposed to antiepileptic drugs in utero. Curr Opin Neurol (2009) 0.86
Neurological and psychiatric sequelae of developmental exposure to antiepileptic drugs. Front Neurol (2012) 0.86
Fetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6years. Epilepsy Behav (2013) 0.85
Major malformations with valproic acid. Can Fam Physician (2006) 0.83
Relationship of child IQ to parental IQ and education in children with fetal antiepileptic drug exposure. Epilepsy Behav (2011) 0.81
The course and outcome of pregnancy and neonatal situation in epileptic women. Adv Biomed Res (2012) 0.81
Effects of in utero antiepileptic drug exposure. Epilepsy Curr (2009) 0.81
In utero valproate exposure and autism: long suspected, finally proven. Epilepsy Curr (2013) 0.81
Animal models of autism: an epigenetic and environmental viewpoint. J Cent Nerv Syst Dis (2010) 0.80
Pregnancy and epilepsy: what should we tell our patients? J Neurol (2009) 0.79
Neurodevelopmental effects of fetal antiepileptic drug exposure. Drug Saf (2015) 0.79
Teratogenic risk and contraceptive counselling in psychiatric practice: analysis of anticonvulsant therapy. BMC Psychiatry (2013) 0.78
Prenatal exposure to carbamazepine reduces hippocampal and cortical neuronal cell population in new-born and young mice without detectable effects on learning and memory. PLoS One (2013) 0.78
Comparative safety of anti-epileptic drugs among infants and children exposed in utero or during breastfeeding: protocol for a systematic review and network meta-analysis. Syst Rev (2014) 0.78
Anatomical and behavioral effects of in utero exposure to antiepileptic drugs. Epilepsy Curr (2005) 0.78
Gene polymorphisms and their role in epilepsy treatment and prognosis. Naunyn Schmiedebergs Arch Pharmacol (2010) 0.77
Management of epilepsy in women. Postgrad Med J (2005) 0.77
The 2008 Judith Hoyer lecture: epilepsy in children: listening to mothers. Epilepsy Behav (2009) 0.76
New developments in the treatment of partial-onset epilepsy. Neuropsychiatr Dis Treat (2012) 0.76
Behavioral outcomes in children exposed prenatally to lamotrigine, valproate, or carbamazepine. Neurotoxicol Teratol (2016) 0.76
An Update on Maternal Use of Antiepileptic Medications in Pregnancy and Neurodevelopment Outcomes. J Pediatr Genet (2015) 0.75
Cognitive outcomes of prenatal antiepileptic drug exposure. Epilepsy Res (2015) 0.75
Long-term consequences after exposure to antiepileptic drugs in utero. Ther Adv Drug Saf (2011) 0.75
Epilepsy during pregnancy: focus on management strategies. Int J Womens Health (2016) 0.75
Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges. Drug Healthc Patient Saf (2014) 0.75
Valproate poses risk to unborn child. Epilepsy Curr (2005) 0.75
Do lamotrigine and levetiracetam solve the problem of using sodium valproate in women with epilepsy? Obstet Med (2012) 0.75
Neurological teratogenic effects of antiepileptic drugs during pregnancy. Exp Ther Med (2016) 0.75
First-degree relative risk: in utero levetiracetam and valproate exposure. Epilepsy Curr (2014) 0.75
Too Complicated or So Simple: AED Type and AED Dose Matter for Pregnancy. Epilepsy Curr (2012) 0.75
Women and epilepsy. J Pediatr Pharmacol Ther (2009) 0.75
Medical management of epileptic seizures: challenges and solutions. Neuropsychiatr Dis Treat (2016) 0.75
Longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry (2004) 0.75
Pregnancy outcome of 149 pregnancies in women with epilepsy: Experience from a tertiary care hospital. Interv Med Appl Sci (2015) 0.75
Trends in maternal deaths from epilepsy in the United Kingdom: a 30-year retrospective review. Obstet Med (2014) 0.75
Neurodevelopmental Effects of Antiepileptic Drugs. Neurochem Res (2017) 0.75
Normal intelligence in children with prenatal exposure to carbamazepine. Neurology (2004) 3.58
Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J Med Genet (2002) 3.30
The teratogenicity of anticonvulsant drugs. N Engl J Med (2001) 3.09
Maternal epilepsy and abnormalities of the fetus and newborn. Lancet (1972) 3.00
Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia (1997) 2.82
Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. JAMA (1994) 2.82
Juvenile myoclonic epilepsy of Janz. Neurology (1984) 2.76
Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med (1989) 2.56
Fetal valproate syndrome. J Med Genet (1995) 2.44
Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry (2001) 2.40
Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy. Lancet (1999) 2.32
A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet (2000) 2.09
The fetal valproate syndrome. Am J Med Genet (1984) 2.04
Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. J Pediatr (1976) 2.00
Malformations in offspring of 305 epileptic women: a prospective study. Acta Neurol Scand (1992) 1.76
Congenital malformations due to antiepileptic drugs. Epilepsy Res (1999) 1.71
Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort. Ann Neurol (2001) 1.56
The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies. J Neurol Neurosurg Psychiatry (2004) 1.55
Carbamazepine versus valproate monotherapy for epilepsy: a meta-analysis. Epilepsia (2002) 1.53
Anticonvulsants and parental epilepsy in the development of birth defects. Lancet (1976) 1.51
Infants exposed in utero to antiepileptic drugs. A prospective study. Am J Dis Child (1974) 1.42
Ten years of presymptomatic testing for Huntington's disease: the experience of the UK Huntington's Disease Prediction Consortium. J Med Genet (2000) 1.35
Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy. Arch Dis Child (1996) 1.35
Intelligence of children of epileptic mothers. J Pediatr (1988) 1.34
Preliminary results on pregnancy outcomes in women using lamotrigine. Epilepsia (2002) 1.24
Population based, prospective study of the care of women with epilepsy in pregnancy. BMJ (2000) 1.22
Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate. Seizure (2002) 1.18
The effects of prenatal exposure to phenytoin and other anticonvulsants on intellectual function at 4 to 8 years of age. Neurotoxicol Teratol (1993) 1.17
Psychomotor development in preschool children exposed to antiepileptic drugs in utero. Acta Paediatr (2002) 1.12
Antiepileptic medication in pregnancy: late effects on the children's central nervous system development. Am J Obstet Gynecol (1991) 1.01
Findings in children exposed in utero to phenytoin and carbamazepine monotherapy: independent effects of epilepsy and medications. Am J Med Genet (1997) 1.01
Specific cognitive dysfunction in children with epileptic mothers. Dev Med Child Neurol (1990) 0.99
Fetal anticonvulsant syndrome and mutation in the maternal MTHFR gene. Clin Genet (1999) 0.97
Epilepsy in pregnancy: developmental outcome of offspring at 12 months. Neurology (1992) 0.96
The psychological development of children of epileptic parents. I. Study design and comparative findings. Acta Paediatr (1994) 0.92
Minor anomalies in children of mothers with epilepsy. Neurology (1992) 0.92
Cortical motor mapping in epilepsy patients: information from subdural electrodes in presurgical evaluation. Epilepsia (2002) 0.91
The teratogenicity of hydantoins and barbiturates in humans, with considerations on the etiology of malformations and cerebral disturbances in the children of epileptic parents. Int J Biol Res Pregnancy (1981) 0.89
Howard Henry Tooth (1856-1925). J Neurol (2000) 0.84
Antiepileptic drug therapy during pregnancy: the neurologist's perspective. J Med Genet (2002) 0.83
Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet (1997) 6.85
New antiepileptic drugs: a systematic review of their efficacy and tolerability. BMJ (1996) 4.73
Isolation, experimental transmission, and characterization of causative agent of Potomac horse fever. Science (1985) 4.12
In utero antiepileptic drug exposure: fetal death and malformations. Neurology (2006) 3.64
Implications of socio-cultural contexts for the ethics of clinical trials. Health Technol Assess (1997) 3.57
Visual evoked responses in the diagnosis and management of patients suspected of multiple sclerosis. Brain (1975) 3.48
Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev (2001) 3.43
Acute effects of particulate air pollution on respiratory admissions: results from APHEA 2 project. Air Pollution and Health: a European Approach. Am J Respir Crit Care Med (2001) 3.40
Generic inhalers for asthma. BMJ (1994) 3.09
Arteriovenous malformations of the brain: natural history in unoperated patients. J Neurol Neurosurg Psychiatry (1986) 2.98
Epidemiology of tuberous sclerosis. Ann N Y Acad Sci (1991) 2.96
The misdiagnosis of epilepsy and the management of refractory epilepsy in a specialist clinic. QJM (1999) 2.52
Effects of breastfeeding in children of women taking antiepileptic drugs. Neurology (2010) 2.38
Angelman syndrome: consensus for diagnostic criteria. Angelman Syndrome Foundation. Am J Med Genet (1995) 2.34
Uniparental paternal disomy in Angelman's syndrome. Lancet (1991) 2.26
Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology (2008) 2.24
A procedure for measurement of distribution spaces in isolated fat cells. Biochim Biophys Acta (1972) 2.22
Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27. Hum Mol Genet (1998) 2.16
An association between type 1 diabetes and idiopathic generalized epilepsy. Ann Neurol (2006) 2.15
Systematic screening allows reduction of adverse antiepileptic drug effects: a randomized trial. Neurology (2004) 2.14
Pseudostatus epilepticus. Q J Med (1989) 2.04
The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. Community study. Epilepsia (1996) 2.00
Nail patella syndrome: a review of the phenotype aided by developmental biology. J Med Genet (2003) 1.95
Mushroom body ablation impairs short-term memory and long-term memory of courtship conditioning in Drosophila melanogaster. Neuron (1999) 1.91
Genetic linkage of cone-rod retinal dystrophy to chromosome 19q and evidence for segregation distortion. Nat Genet (1994) 1.91
Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol Scand (2003) 1.90
Mutations in transcriptional regulator ATRX establish the functional significance of a PHD-like domain. Nat Genet (1997) 1.88
Diabetes risk factors in low-income Mexican-American children. Diabetes Care (1999) 1.82
Outcome of low vision aid provision: the effectiveness of a low vision clinic. Optom Vis Sci (1994) 1.80
Exchange of 3-O-methylglucose in isolated fat cells. Concentration dependence and effect of insulin. J Biol Chem (1976) 1.79
Meier-Gorlin syndrome: report of eight additional cases and review. Am J Med Genet (2001) 1.76
Patients' experiences of injury as a result of epilepsy. Epilepsia (1997) 1.73
How easy are randomized controlled trials in epilepsy to find on Medline? The sensitivity and precision of two Medline searches. Epilepsia (1996) 1.73
The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia (1997) 1.72
A clinical and genetic study of the Say/Barber/Biesecker/Young-Simpson type of Ohdo syndrome. Clin Genet (2008) 1.71
Standards of care for occupational asthma. Thorax (2007) 1.70
Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. J Med Genet (2001) 1.66
Paternal origin of new mutations in von Recklinghausen neurofibromatosis. Nature (1990) 1.64
Neuropsychological effects of exposure to anticonvulsant medication in utero. Neurology (2005) 1.63
Non-disjunction of chromosome 18. Hum Mol Genet (1998) 1.62
Imprinting mutation in the Beckwith-Wiedemann syndrome leads to biallelic IGF2 expression through an H19-independent pathway. Hum Mol Genet (1996) 1.57
The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies. J Neurol Neurosurg Psychiatry (2004) 1.55
A general practice records audit of the process of care for people with epilepsy. Br J Gen Pract (1996) 1.53
New drug treatments for epilepsy. J Neurol Neurosurg Psychiatry (2001) 1.50
Primary immunisations in Liverpool. II: Is there a gap between consent and completion? Arch Dis Child (1993) 1.49
Assisted reproductive therapies and imprinting disorders--a preliminary British survey. Hum Reprod (2005) 1.48
High fertilization rate with intracytoplasmic sperm injection in mosaic Klinefelter's syndrome. Fertil Steril (1995) 1.48
Pleuropulmonary blastoma in childhood. A malignant degeneration of pulmonary cysts. Pediatr Surg Int (2004) 1.47
Detection of differentially expressed genes in primary tumor tissues using representational differences analysis coupled to microarray hybridization. Nucleic Acids Res (1998) 1.46
Continuous subcutaneous bronchodilators in brittle asthma. Br J Hosp Med (1992) 1.46
Accurate diagnosis of convulsive syncope: role of an implantable subcutaneous ECG monitor. Seizure (1999) 1.44
Biliary atresia in Kabuki syndrome. Am J Med Genet (2000) 1.43
Controlled trial of plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet (1984) 1.43
Update on Kleefstra Syndrome. Mol Syndromol (2012) 1.42
Clinical and hematologic aspects of the X-linked alpha-thalassemia/mental retardation syndrome (ATR-X). Am J Med Genet (1995) 1.42
A comparison of three procedures to assess the motor ability of 12-month-old infants with cerebral palsy. Dev Med Child Neurol (1993) 1.41
Effect of endurance training on glucose transport capacity and glucose transporter expression in rat skeletal muscle. Am J Physiol (1990) 1.40
Seizures provoked by blows to the head. Epilepsia (2000) 1.40
Primary immunisations in Liverpool. I: Who withholds consent? Arch Dis Child (1993) 1.40
Predictors of clinical hypomagnesemia. Hypokalemia, hypophosphatemia, hyponatremia, and hypocalcemia. Arch Intern Med (1984) 1.40
The cutaneous features of tuberous sclerosis: a population study. Br J Dermatol (1996) 1.40
The role of molecular genetics in the prenatal diagnosis of retinal dystrophies. Eye (Lond) (1995) 1.39
A meta-analysis of individual patient responses to lamotrigine or carbamazepine monotherapy. Neurology (2006) 1.39
Nucleolar organiser regions in small cell carcinoma of the bronchus. Thorax (1987) 1.38
Which drug for the adult epileptic patient: phenytoin or valproate? Br Med J (Clin Res Ed) (1985) 1.36
A maternal hypomethylation syndrome presenting as transient neonatal diabetes mellitus. Hum Genet (2006) 1.35
Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones. Mol Pharmacol (2003) 1.35
Hospital admission rates for asthma and respiratory disease in the West Midlands: their relationship to air pollution levels. Thorax (1995) 1.34
Adipose thyrotrophin receptor expression is elevated in Graves' and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo. J Mol Endocrinol (2003) 1.33
Screening for submicroscopic chromosome rearrangements in children with idiopathic mental retardation using microsatellite markers for the chromosome telomeres. J Med Genet (1999) 1.31
The prognosis of primary intracerebral tumours presenting with epilepsy: the outcome of medical and surgical management. J Neurol Neurosurg Psychiatry (1991) 1.31
Clinical spectrum of SIX3-associated mutations in holoprosencephaly: correlation between genotype, phenotype and function. J Med Genet (2009) 1.31
Expression of insulin regulatable glucose transporters in skeletal muscle from type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1990) 1.30
Human leptospirosis from immunized dogs. Ann Intern Med (1973) 1.29
Pregnancy with epilepsy: obstetric and neonatal outcome of a controlled study. Seizure (2009) 1.28
Mutational analysis of familial and sporadic hyperekplexia. Ann Neurol (1995) 1.28
Phenotypic variability and asymmetry of Rieger syndrome associated with PITX2 mutations. Invest Ophthalmol Vis Sci (2000) 1.26
Diagnostic criteria, clinical characteristics, and natural history of Cohen syndrome. J Med Genet (2003) 1.26
New domains of neural cell-adhesion molecule L1 implicated in X-linked hydrocephalus and MASA syndrome. Am J Hum Genet (1995) 1.25
Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males. Lancet (2000) 1.24
The clinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviews. Health Technol Assess (2006) 1.24
Rabbit muscle creatine phosphokinase. CDNA cloning, primary structure and detection of human homologues. J Biol Chem (1984) 1.24
Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial. Eur Respir J (2002) 1.23
Coats' disease of the retina (unilateral retinal telangiectasis) caused by somatic mutation in the NDP gene: a role for norrin in retinal angiogenesis. Hum Mol Genet (1999) 1.22
Aarskog-Scott syndrome: clinical update and report of nine novel mutations of the FGD1 gene. Am J Med Genet A (2010) 1.21
Pheochromocytoma without hypertension presenting as cardiomyopathy. Am Heart J (1972) 1.21
Delayed diagnosis of Duchenne muscular dystrophy. Eur J Paediatr Neurol (2000) 1.20
A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial. Health Technol Assess (2007) 1.18
Factors influencing compliance with antiepileptic drug regimes. Seizure (1997) 1.18
Deletions involving long-range conserved nongenic sequences upstream and downstream of FOXL2 as a novel disease-causing mechanism in blepharophimosis syndrome. Am J Hum Genet (2005) 1.18
Perceptions of healthy eating and physical activity in an ethnically diverse sample of young children and their parents: the DEAL prevention of obesity study. J Hum Nutr Diet (2012) 1.17